Emma B. Dean
Emma B. Dean
Assistant Professor of Health Management and Policy, University of Miami
Verified email at - Homepage
Cited by
Cited by
Poverty and cognitive function
EB Dean, F Schilbach, H Schofield
The economics of poverty traps, 57-118, 2017
Government fragmentation and public goods provision
G Grossman, JH Pierskalla, E Boswell Dean
The Journal of Politics 79 (3), 823-840, 2017
Food insecurity, health care utilization, and health care expenditures
EB Dean, MT French, K Mortensen
Health services research 55, 883-893, 2020
Physician, practice, and patient characteristics associated with biosimilar use in Medicare recipients
EB Dean, P Johnson, AM Bond
JAMA network open 4 (1), e2034776-e2034776, 2021
Who benefits from pharmaceutical price controls? Evidence from India
EB Dean
Center for Global Development, 2019
The future of global health procurement: issues around pricing transparency
M Berdud, K Chalkidou, EB Dean, J Ferraro, L Garrison, C Nemzoff, ...
Center for Global Development 50 (7), 27-31, 2019
Using Administrative Data to examine telemedicine usage among Medicaid beneficiaries during the Coronavirus Disease 2019 Pandemic
M Hossain, EB Dean, D Kaliski
Medical care 60 (7), 488-495, 2022
Trends in health care utilization and expenditures in the United States across 5 decades: 1977–2017
K Mortensen, EB Dean, MT French, N Wang, J Chen
Medical care 59 (8), 704-710, 2021
The economics of poverty traps
EB Dean, F Schilbach, H Schofield
National Bureau of Economic Research, Washington, DC, 2017
The Role Of Financial Incentives In Biosimilar Uptake In Medicare: Evidence From The 340B Program: Study examines the role of financial incentives in the uptake of biosimilar …
AM Bond, EB Dean, SM Desai
Health Affairs 42 (5), 632-641, 2023
Poverty and cognitive function The Economics of Poverty Traps
EB Dean, F Schilbach, H Schofield
University of Chicago Press, 2017
Who benefits from pharmaceutical price ceilings
EB Dean
Evidence from India, 2017
Changes in medicare part B spending for biologic drugs after biosimilar entry into the market
EB Dean, AM Bond
JAMA health forum 2 (9), e212634-e212634, 2021
Role of Supply Chain Intermediaries in Steering Hospital Product Choice: Group Purchasing Organizations and Biosimilars
EB Dean, R Pierre, S Carter, AM Bond
Health Affairs Scholar, qxae067, 2024
Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization
E Boswell Dean, J Feng, L Maini
Available at SSRN 4578352, 2023
Institutional Innovation for Neglected Diseases: The Case of the Priority Review Voucher
LX Wang, E Dean, S Sylvia
ASHEcon 2024 Conference, 2024
Opioids and Health
E Dean, Y Ge
2023 APPAM Fall Research Conference, 2023
Financial Incentives In Biosimilar Uptake: The Authors Reply: A response letter to the Editor about financial incentives in biosimilar uptake
AM Bond, EB Dean, S Desai
Health Affairs 42 (9), 1308-1308, 2023
Dengvaxia Controversy and Children's Vaccination in the Philippines
J Yang, E Dean
2023 World Congress on Health Economics, 2023
To Pool or Not to Pool? National Vs. Global Incentives in Pooled Purchasing
E Dean, E Saltzman
2023 World Congress on Health Economics, 2023
The system can't perform the operation now. Try again later.
Articles 1–20